# A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly Subjects

> **NCT01514825** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 36 (actual)

## Conditions studied

- Healthy Elderly Subject
- Pharmacokinetic of YM150

## Interventions

- **DRUG:** YM150
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01514825
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-02
- **Final completion:** 2007-02
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2012-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01514825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01514825, "A Study to Investigate the Plasma Concentration of YM150 After Repeated Administration to Elderly Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01514825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*